Catheterization and Cardiovascular Interventions

Article	Citations
Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams	94
Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: A novel method based on bifurcation fractal law	91
Impact of COVID‐19 pandemic on ST‐elevation myocardial infarction in a non‐COVID‐19 epicenter	87
Management of acute myocardial infarction during the COVID‐19 pandemic	86
SCAI shock classification in acute myocardial infarction: Insights from the National Cardiogenic Shock Initiative	66
SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease	63
Prospective validation of the SCAI shock classification: Single center analysis	60
Impact of COVID‐19 pandemic on STEMI care: An expanded analysis from the United States	57
European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions	55
Percutaneous mechanical thrombectomy in a real‐world pulmonary embolism population: Interim results of the FLASH registry	55
Impact of coronavirus disease 2019 (COVID‐19) outbreak on outcome of myocardial infarction in Hong Kong, China	50
Changes in characteristics and management among patients with ST‐elevation myocardial infarction due to COVID‐19 infection	45
Radial versus femoral access for coronary interventions: An updated systematic review and meta‐analysis of randomized trials	44
Correction of sinus venosus atrial septal defects with the 10 zig covered Cheatham‐platinum stent – An international registry	37
Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study	36
Coronary microcirculation assessment using functional angiography: Development of a wire‐free method applicable to conventional coronary angiograms	34
Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolism	32
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)	31
BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients	31
SCAI cardiogenic shock classification after out of hospital cardiac arrest and association with outcome	31
Robotic telestenting performance in transcontinental and regional pre‐clinical models	31
Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock	30
Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock	30
Micropuncture technique for femoral access is associated with lower vascular complications compared to standard needle	29
Acute myocardial infarction and large coronary thrombosis in a patient with COVID‐19	29

12‐Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation	29
Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN‐TAVI registry	29
SCAI expert consensus update on best practices in the cardiac catheterization laboratory	28
Safety of same‐day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID‐19 era	28
Triage considerations for patients referred for structural heart disease intervention during the COVID‐19 pandemic: An ACC/SCAI position statement	27
Incidence, predictors and outcomes of device‐related thrombus after left atrial appendage closure with the WATCHMAN device—Insights from the EWOLUTION real world registry	27
Impact of the COVID‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter	26
Efficacy of drug‐coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry)	25
Consequences of canceling elective invasive cardiac procedures during Covid‐19 outbreak	24
SCAI expert consensus statement on out of hospital cardiac arrest	23
Ten year follow‐up of high‐risk patients treated during the early experience with transcatheter aortic valve replacement	23
Dedicated plug based closure for large bore access –The MARVEL prospective registry	23
Paclitaxel exposure: Long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials	23
Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population	23
Access site related vascular complications with third generation transcatheter heart valve systems	22
Drug‐Coated balloons vs drug‐eluting stents for the treatment of small coronary artery disease: A meta‐analysis of randomized trials	22
Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study	21
COVID‐19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock	21
Severe coronary spasm in a COVID‐19 patient	21
Clinical impact of intravascular ultrasound‐guided balloon angioplasty in patients with chronic limb threatening ischemia for isolated infrapopliteal lesion	21
Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study	20
Uncrossable and undilatable lesions—A practical approach to optimizing outcomes in PCI	20
Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials	20
Cardiac procedural deferral during the coronavirus (COVID‐19) pandemic	20
Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN‐CTO registry	20
Surgical redo versus transseptal or transapical transcatheter mitral valve‐in‐valve implantation for failed mitral valve bioprosthesis	20
Mid‐term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract	20
Impact of the COVID‐19 pandemic on interventional cardiology training in the United States	20
Balloon versus self‐expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta‐analysis of observational studies	20
Intravascular lithotripsy in calcified‐coronary lesions: A real‐world observational, European multicenter study	20
SCAI guidelines on device selection in Aorto‐Iliac arterial interventions	20
Sex‐stratified analysis of the safety of percutaneous left atrial appendage occlusion	20
Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut‐R, Portico, and Acurate‐NEO	19
National trends of utilization and readmission rates with intravascular ultrasound use for ST‐elevation myocardial infarction	19
Clinical and procedural characteristics of COVID‐19 patients treated with percutaneous coronary interventions	19
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF	19
Robotic‐assisted percutaneous coronary intervention in a COVID‐19 patient	19
Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease	18
Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN‐TAVI registry	18
Outcomes of mechanical circulatory support for acute myocardial infarction complicated by cardiogenic shock	18
Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN‐CLEAN perforation score	18
Transcaval access for the emergency delivery of 5.0 liters per minute mechanical circulatory support in cardiogenic shock	18
Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity	18
Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5‐year follow‐up in a French Registry	18
Percutaneous mitral valve repair in adults with congenital heart disease: Report of the first case‐series	17
Effect of a fourth‐generation transcatheter valve enhanced skirt on paravalvular leak	17
SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 registry	17
Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry	16
Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization	16
Cerebral protection in left atrial appendage closure in the presence of appendage thrombosis	16

Pressure‐controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI	16
Rates and impact of vascular complications in mechanical circulatory support	16
Combined use of intravascular lithotripsy and brachytherapy: A new approach for the treatment of recurrent coronary in‐stent restenosis	16
Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi‐center registry	16
Use of edge‐to‐edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA‐SHOCK study)	16
5‐Year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters	16
Breaking the deadlock of calcified coronary artery lesions: A contemporary review	16
Next‐generation balloon‐expandable Myval transcatheter heart valve in low‐risk aortic stenosis patients	15
Non‐invasive procedural planning using computed tomography‐derived fractional flow reserve	15
Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery	15
Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study	15
Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial	15
Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement	15
Effectiveness and safety of same day discharge after left atrial appendage closure under moderate conscious sedation	15
An algorithmic approach to balloon‐uncrossable coronary lesions	15
Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry	15
Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention	14
Five‐year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration	14
Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement	14
Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience	14
Histopathologic analysis of extracted thrombi from deep venous thrombosis and pulmonary embolism: Mechanisms and timing	14
One‐year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC‐HOT study	14
Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience	14
Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30‐day results	14
Management of peri‐device leak following left atrial appendage closure: A systematic review	14
Valve‐in‐valve transcatheter aortic valve replacement versus redo surgical valve replacement for degenerated bioprosthetic aortic valve: An updated meta‐analysis comparing midterm outcomes	13
Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience	13
Influence of intra‐aortic balloon pump on mortality as a function of cardiogenic shock severity	13
Conventional versus modified delivery system technique in commissural alignment from the Evolut low‐risk CT substudy	13
Robotic‐assisted balloon angioplasty and stent placement with distal embolic protection device for severe carotid artery stenosis in a high‐risk surgical patient	13
Stenting techniques for coronary bifurcation lesions: Evidence from a network meta‐analysis of randomized clinical trials	13
Novel insights on outcome in horizontal aorta with self‐expandable new‐generation transcatheter aortic valve replacement devices	13
Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI‐shock registry results	13
Sex‐specific in‐hospital outcomes of transcatheter aortic valve replacement with third generation transcatheter heart valves	13
Angiography‐derived versus invasively‐determined index of microcirculatory resistance in the assessment of coronary microcirculation: A systematic review and meta‐analysis	13
Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users	12
Optical coherence tomography analysis of late lumen enlargement after paclitaxel‐coated balloon angioplasty for de‐novo coronary artery disease	12
Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study	12
Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry	12
Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion‐percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Cros	12
Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome	12
Mortality and functional outcomes of endovascular stroke therapy in the United States	12
Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID‐19 patient with ST‐elevation myocardial infarction	12
Safety and efficacy of mechanical circulatory support with Impella or intra‐aortic balloon pump for high‐risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta‐	12
Predictors and potential advantages of PERT and advanced therapy use in acute pulmonary embolism	12
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia‐free ratio versus fractional flow reserve in non‐culprit lesion of patients with non ST‐segment el	12
Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation	12
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy	12
Association between surgical risk and 30‐day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta‐analysis	12
Short term outcomes of Impella circulatory support for high‐risk percutaneous coronary intervention a systematic review and meta‐analysis	12
Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID‐19 infection	12
Long‐term results of a prospective, single‐arm evaluation of everolimus‐eluting bioresorbable vascular scaffolds in infrapopliteal arteries	12
Four‐year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3	11
Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity	11
Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta‐analysis	11
SCAI position statement on the performance of percutaneous coronary intervention in ambulatory surgical centers	11
Predictors of optimal procedural result after transcatheter edge‐to‐edge mitral valve repair in secondary mitral regurgitation	11
Propensity‐matched comparison of large‐bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real‐world experience	11
Meta‐analysis of intravascular volume expansion strategies to prevent contrast‐associated acute kidney injury following invasive angiography	11
Meta‐analysis comparing valve‐in‐valve TAVR and redo‐SAVR in patients with degenerated bioprosthetic aortic valve	11
A single healthcare experience with Impella RP	11
Patients with COVID‐19 who experience a myocardial infarction have complex coronary morphology and high in‐hospital mortality: Primary results of a nationwide angiographic study	11
Outflow graft obstruction in patients with the HM 3 LVAD: A percutaneous approach	11
Sex differences in high‐risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry	11
Preliminary testing and evaluation of the renata minima stent, an infant stent capable of achieving adult dimensions	11
Catheter directed embolectomy of right atrial clot in transit‐A case series	11
Cusp‐overlap versus coplanar view in transcatheter aortic valve implantation with self‐expandable valves: A meta‐analysis of comparative studies	11
Real‐world experience of suture‐based closure devices: Insights from the FDA Manufacturer and User Facility Device Experience	11
Vascular complications with a plug‐based vascular closure device after transcatheter aortic valve replacement: Predictors and bail‐outs	11
Percutaneous large‐bore axillary access is a safe alternative to surgical approach: A systematic review	11
Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and c	11
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12‐month results from a proof‐of‐principle trial	11
Incidence and predictors of delirium on the intensive care unit after acute myocardial infarction, insight from a retrospective registry	11
Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices	11
Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program	11
Outcomes of urgent/emergent transcatheter mitral valve repair (MitraClip): A single center experience	11
Incidence and time course of atrial fibrillation following patent foramen ovale closure	10
Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair	10
Short‐term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States	10
Correlation between 3D‐QCA based FFR and quantitative lumen assessment by IVUS for left main coronary artery stenoses	10

Transradial approach for carotid artery stenting: A position paper from the Italian Society of Interventional Cardiology (SICI‐GISE)	10
Intracardiac echocardiography for guidance of transcatheter left atrial appendage occlusion: An expert consensus document	10
Evaluation of a suspended radiation protection system to reduce operator exposure in cardiology interventional procedures	10
30‐day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis	10
Intravascular imaging for left main stem assessment: An update on the most recent clinical data	10
Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention	10
First‐in‐human transcatheter pledget‐assisted suture tricuspid annuloplasty for severe tricuspid insufficiency	10
Endovascular treatment of femoro‐popliteal occlusions with retrograde tibial access after failure of the antegrade approach	10
Atrial flow regulator for drug‐resistant pulmonary hypertension in a young child	10
Left main coronary artery compression in pulmonary hypertension	10
Diagnostic performance and prognostic impact of coronary angiography‐based Index of Microcirculatory Resistance assessment: A systematic review and meta‐analysis	10
Sex differences in outcomes of transcatheter edge‐to‐edge repair with MitraClip: A meta‐analysis	10
Functional coronary angiography in symptomatic patients with no obstructive coronary artery disease	10
The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: Results from the DANAMI‐3‐PRIMULTI randomized study	10
Long‐term durability of self‐expanding and balloon‐expandable transcatheter aortic valve prostheses: UK TAVI registry	10
Virtual support for remote proctoring in TAVR during COVID‐19	10
Impact of stent length and diameter on 10‐year mortality in the SYNTAXES trial	10
Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in ma	10
Early experience with the Micro Plug Set for preterm patent ductus arteriosus closure	9
Shockwave intravascular lithoplasty for the treatment of calcified carotid artery stenosis: A very early single‐center experience	9
Combined rotational atherectomy and cutting balloon angioplasty prior to drug‐eluting stent implantation in severely calcified coronary lesions: The PREPARE‐CALC‐COMBO study	9
Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high‐risk patients: The e‐Cobra study	9
Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions	9
Mortality in spontaneous coronary artery dissection: A systematic review and meta‐analysis	9
SCAI initiatives during the COVID‐19 pandemic	9
Iatrogenic catheter‐induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years	9
Elective versus urgent in‐hospital transcatheter aortic valve implantation	9
Snuffbox approach for balloon aortic valvuloplasty: A case series	9
Leak closure following left atrial appendage exclusion procedures: A multicenter registry	9
Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation	9
Iatrogenic atrial septal defect following the MitraClip procedure: A state‐of‐the‐art review	9
Prognostic significance of right ventricle to pulmonary artery coupling in patients with mitral regurgitation treated with the MitraClip system	9
Aortic stenosis in the time of COVID‐19: Development and outcomes of a rapid turnaround TAVI service	9
Mid‐term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population	9
Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention	9
Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies	9
Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock	9
Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial	9
An interventional approach to left ventricular assist device outflow graft obstruction	9
Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention	9
Validation of novel 3‐dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting	9
Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials	9
Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta‐analysis of over 3,000 patients	9
The “lend a hand” external bypass technique: External radial to femoral bypass for antegrade perfusion of an ischemic limb with occlusive large bore sheath ‐ A novel and favorable approach	9
Self‐expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management	9
International percutaneous coronary intervention complication survey	9
Rate, causes, and predictors of 90‐day readmissions and the association with index hospitalization coronary revascularization following non‐ST elevation myocardial infarction in	9
Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients	9
Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve replacement: A meta‐analysis	9
Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry	9
Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome	9
Early and late outcomes of surgical aortic valve replacement with sutureless and rapid‐deployment valves versus transcatheter aortic valve implantation: Meta‐analysis with reconstructed time‐to‐event	9
Excimer laser coronary atherectomy during complex PCI: An analysis of 1,471 laser cases from the British Cardiovascular Intervention Society database	8
Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry	8
Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high‐risk diabetic population from the OCEAN‐TAVI registry	8
Clinical outcome of patients with ST‐elevation myocardial infarction and angiographic evidence of coronary artery ectasia	8
Efficacy of the novel inner PIERCE technique for severely calcified below‐the‐knee occlusions in a patient with chronic limb‐threatening ischemia	8
Automation of intracoronary continuous thermodilution for absolute coronary flow and microvascular resistance measurements	8
Mid‐term follow‐up of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: An experience in Latin America	8
Tricuspid valve vegetation debulking using the AngioVac system	8
Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS‐CTO registry	8
Short‐ and mid‐term outcomes in percutaneous mitral valve replacement using balloon expandable valves	8
Safety of transradial access compared to transfemoral access with hemostatic devices (vessel plugs and suture devices) after percutaneous coronary interventions: A systematic review and meta‐anal	8
Safety of the transradial approach to carotid stenting	8
Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST‐segment elevation myocardial infarction	8
The hemodynamic spectrum of pulmonary vein stenosis from fibrosing mediastinitis	8
A patient‐specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique	8
Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent	8
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project	8
Transcarotid versus transfemoral access in patients undergoing transcatheter aortic valve replacement with complex aortofemoral anatomy	8
Prognostic value of quantitative flow ratio measured immediately after drug‐coated balloon angioplasty for in‐stent restenosis	8
Effect of prehospital treatment in STEMI patients undergoing primary PCI	8
Comparison of clinical results between percutaneous closure and surgical repair of ruptured sinus of Valsalva aneurysm	8
Dose‐reducing fluoroscopic system decreases patient but not occupational radiation exposure in chronic total occlusion intervention	8
Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry	8
Iatrogenic aorta‐coronary dissection: Case report and systematic review	8
Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks	8
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry	8
Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta‐analysis	8
Outcomes of in‐hospital cardiac arrest in COVID‐19 patients: A proportional prevalence meta‐analysis	8
Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease	7
Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5‐year clinical experience	7
Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement	7
Early coronary angiography in patients after out‐of‐hospital cardiac arrest without ST‐segment elevation: Meta‐analysis of randomized controlled trials	7
Valve‐in‐valve transcatheter aortic valve replacement or re‐surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta‐analysis of short and midterm results	7
Adapting STEMI care for the COVID‐19 pandemic: The case for low‐risk STEMI triage and early discharge	7
Revascularization of coronary chronic total occlusions in an infarct‐related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibril	7
Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool	7
Transcatheter cerebral embolic protection during WATCHMAN procedure in two patients with persistent left atrial appendage thrombus: Case report with review of the literature	7
Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial	7
First in‐human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging	7
Revascularisation strategies in patients with significant left main coronary disease during the COVID‐19 pandemic	7
Impact of malnutrition and frailty on mortality and major amputation in patients with CLTI	7
Randomized trial comparing radial hemostasis techniques; catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band	7
Three‐year survival of transcatheter versus surgical aortic valve replacement in dialysis	7